Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
AVTR expands Masterflex across its fluid handling portfolio, aiming to streamline workflows and boost scalable bioprocessing adoption.
Avantor Stock Up as New Lab Capabilities Improve Biopharma Support
AVTR stock gains after expanding U.S. lab capabilities, boosting biopharma support, streamlining testing and strengthening supply chain efficiency.
New Strong Sell Stocks for March 17th
AVTR, COIN and CMG have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2026.
